SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $262,000 | +13.4% | 1,538 | -6.4% | 0.98% | +681.7% |
| Q3 2020 | $231,000 | -17.2% | 1,644 | -5.7% | 0.13% | -23.6% |
| Q2 2020 | $279,000 | -12.5% | 1,743 | -29.6% | 0.16% | +19.6% |
| Q1 2020 | $319,000 | 0.0% | 2,475 | 0.0% | 0.14% | +22.1% |
| Q4 2019 | $319,000 | -12.6% | 2,475 | +3.2% | 0.11% | -21.5% |
| Q2 2019 | $365,000 | -61.3% | 2,399 | -69.7% | 0.14% | -58.7% |
| Q1 2019 | $943,000 | +20.6% | 7,914 | +10.4% | 0.35% | -63.3% |
| Q4 2018 | $782,000 | – | 7,166 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |